{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:50:58Z","timestamp":1792608658163,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cbpa.2022.102211","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T17:06:26Z","timestamp":1663434386000},"page":"102211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)\u2606"],"prefix":"10.1016","volume":"71","author":[{"given":"Khaled A.","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Taha","family":"Moutaoufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Zilocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Phanse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-6406","authenticated-orcid":false,"given":"Mohan","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2022.102211_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnmol.2017.00121","article-title":"Purkinje cell degeneration and motor coordination deficits in a new mouse model of autosomal recessive spastic ataxia of charlevoix-saguenay","volume":"10","author":"Ding","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cbpa.2022.102211_sref2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/72769","article-title":"ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF","volume":"24","author":"Engert","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.cbpa.2022.102211_sref3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jmb.2010.05.023","article-title":"The sacsin repeating region (SRR): a novel Hsp90-related supra-domain associated with neurodegeneration","volume":"400","author":"Anderson","year":"2010","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.cbpa.2022.102211_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/156802606777812031","article-title":"Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site","volume":"6","author":"Hadden","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cbpa.2022.102211_sref5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/humu.22269","article-title":"Comparative analysis and functional mapping of SACS mutations reveal novel insights into sacsin repeated architecture","volume":"34","author":"Romano","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cbpa.2022.102211_sref6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddp067","article-title":"The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1","volume":"18","author":"Parfitt","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2022.102211_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp-2012-303634","article-title":"The ARSACS phenotype can include supranuclear gaze palsy and skin lipofuscin deposits","volume":"84","author":"Stevens","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cbpa.2022.102211_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3174\/ajnr.A0603","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 patients","volume":"28","author":"Martin","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.cbpa.2022.102211_bib9","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/hmg\/ddw173","article-title":"A\u00a0reduction in Drp1-mediated fission compromises mitochondrial health in autosomal recessive spastic ataxia of Charlevoix Saguenay","volume":"25","author":"Bradshaw","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2022.102211_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48047-x","article-title":"Functional transcriptome analysis in ARSACS KO cell model reveals a role of sacsin in autophagy","volume":"9","author":"Morani","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2022.102211_bib11","first-page":"3130","article-title":"Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin","volume":"26","author":"Duncan","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2022.102211_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-019-0438-3","article-title":"Sacs R272C missense homozygous mice develop an ataxia phenotype","volume":"12","author":"Lariviere","year":"2019","journal-title":"Mol Brain"},{"key":"10.1016\/j.cbpa.2022.102211_sref13","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1096\/fj.201801556R","article-title":"Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics","volume":"33","author":"Gentil","year":"2019","journal-title":"Faseb J"},{"key":"10.1016\/j.cbpa.2022.102211_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddu491","article-title":"Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"24","author":"Lariviere","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cbpa.2022.102211_sref15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.1113166109","article-title":"Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)","volume":"109","author":"Girard","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2022.102211_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.cbpa.2022.102211_sref17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1083\/jcb.143.2.351","article-title":"A\u00a0human dynamin-related protein controls the distribution of mitochondria","volume":"143","author":"Smirnova","year":"1998","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.cbpa.2022.102211_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A\u00a0global reference for human genetic variation","volume":"526","author":"Genomes Project","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102211_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cbpa.2022.102211_bib20","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"ClinGen sequence variant interpretation working G: updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cbpa.2022.102211_bib21","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"Predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2022.102211_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.585136","article-title":"Case report: expanding the genetic and phenotypic spectrum of autosomal recessive spastic ataxia of charlevoix-saguenay","volume":"11","author":"Habibzadeh","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.cbpa.2022.102211_sref23","doi-asserted-by":"crossref","first-page":"e2315","DOI":"10.1212\/WNL.0000000000012962","article-title":"Assessment of sacsin turnover in patients with ARSACS: implications for molecular diagnosis and pathogenesis","volume":"97","author":"Longo","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.cbpa.2022.102211_bib24","article-title":"Functional network profiles in ARSACS disclosed by aptamer-based proteomic technology","volume":"11","author":"Morani","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.cbpa.2022.102211_bib25","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1113\/JP275902","article-title":"Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS","volume":"596","author":"Ady","year":"2018","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cbpa.2022.102211_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109281","article-title":"The blood biomarkers puzzle - a review of protein biomarkers in neurodegenerative diseases","volume":"361","author":"Barro","year":"2021","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.cbpa.2022.102211_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2559.2004.01794.x","article-title":"Post mortem sampling of the brain and other tissues in neurodegenerative disease","volume":"44","author":"Love","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.cbpa.2022.102211_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuint.2018.04.013","article-title":"Mitochondrial alterations in Parkinson's disease human samples and cellular models","volume":"118","author":"Zilocchi","year":"2018","journal-title":"Neurochem Int"},{"key":"10.1016\/j.cbpa.2022.102211_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroscience.2016.01.067","article-title":"Human dermal fibroblasts in psychiatry research","volume":"320","author":"Kalman","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbpa.2022.102211_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12035-012-8245-1","article-title":"Primary skin fibroblasts as a model of Parkinson's disease","volume":"46","author":"Auburger","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.cbpa.2022.102211_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2013.10.050","article-title":"White matter astrocytes in health and disease","volume":"276","author":"Lundgaard","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbpa.2022.102211_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000514","article-title":"Quiescent fibroblasts exhibit high metabolic activity","volume":"8","author":"Lemons","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cbpa.2022.102211_bib33","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.2741\/3506","article-title":"Macrophages and fibroblasts during inflammation, tissue damage and organ injury","volume":"14","author":"Glaros","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.cbpa.2022.102211_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(01)00393-1","article-title":"The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders","volume":"26","author":"Lewis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbpa.2022.102211_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12452-x","article-title":"Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern","volume":"7","author":"Kang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2022.102211_bib36","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4103\/1673-5374.211180","article-title":"Using induced pluripotent stem cells derived neurons to model brain diseases","volume":"12","author":"McKinney","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.cbpa.2022.102211_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.scr.2018.09.006","article-title":"Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling","volume":"32","author":"Bianchi","year":"2018","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.cbpa.2022.102211_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuron.2018.10.007","article-title":"Building models of brain disorders with three-dimensional organoids","volume":"100","author":"Amin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.cbpa.2022.102211_sref39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature25032","article-title":"The rise of three-dimensional human brain cultures","volume":"553","author":"Pasca","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102211_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature22330","article-title":"Assembly of functionally integrated human forebrain spheroids","volume":"545","author":"Birey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2022.102211_bib41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.isci.2019.08.057","article-title":"Rewiring of the human mitochondrial interactome during neuronal reprogramming reveals regulators of the respirasome and neurogenesis","volume":"19","author":"Moutaoufik","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.cbpa.2022.102211_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.102030","article-title":"From fuzziness to precision medicine: on the rapidly evolving proteomics with implications in mitochondrial connectivity to rare human disease","volume":"24","author":"Aly","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cbpa.2022.102211_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1172-8-41","article-title":"Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum","volume":"8","author":"Synofzik","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cbpa.2022.102211_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127574","article-title":"Parathyroid hormone, cognitive function and dementia: a systematic review","volume":"10","author":"Lourida","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2022.102211_bib45","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1210\/jc.2014-1736","article-title":"Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts","volume":"99","author":"Hagstrom","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cbpa.2022.102211_bib46","first-page":"1","article-title":"A\u00a0map of human mitochondrial protein interactions linked to neurodegeneration reveals new mechanisms of redox homeostasis and NF-kappaB signaling","volume":"5","author":"Malty","year":"2017","journal-title":"Cell Syst"},{"key":"10.1016\/j.cbpa.2022.102211_bib47","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","article-title":"Synthetic lethality in cancer therapeutics: the next generation","volume":"11","author":"Setton","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cbpa.2022.102211_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1871527317666180419115029","article-title":"Current and promising therapies in autosomal recessive ataxias","volume":"17","author":"Picher-Martel","year":"2018","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.cbpa.2022.102211_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42466-020-00075-z","article-title":"Gene specific therapies - the next therapeutic milestone in neurology","volume":"2","author":"Brenner","year":"2020","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.cbpa.2022.102211_bib50","article-title":"Is viral vector gene delivery more effective using biomaterials?","volume":"10","author":"Wang","year":"2021","journal-title":"Adv Healthc Mater"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593122000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:50:46Z","timestamp":1761274246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593122000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"alternative-id":["S1367593122000965"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102211","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)\u2606","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2022.102211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102211"}}